Celebrating Brain Awareness Week 2025 with CCF: Shining a Light on Brain Health

Celebrating Brain Awareness Week 2025 with CCF: Shining a Light on Brain Health

At the Coleen Cunningham Foundation (CCF), we’re excited to join the global community in recognizing Brain Awareness Week, running from March 10-16, 2025. This annual campaign, led by the Dana Foundation, is a time to celebrate the wonders of the brain, raise awareness about brain health, and highlight the importance of research into neurological conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Corticobasal Degeneration (CBD)—the atypical Parkinsonism disorders at the heart of our mission. 

The brain is an extraordinary organ, home to 100 billion neurons that orchestrate every thought, movement, and emotion. Brain Awareness Week reminds us how vital it is to understand this complex system, especially for those living with atypical Parkinsonism and their families. At CCF, we’re committed to ensuring that No One Walks Alone on this journey, and this week offers a powerful opportunity to amplify that message.

Why Brain Awareness Week Matters to Us

For individuals and families touched by PSP, MSA, DLB, or CBD, the brain’s mysteries can feel both fascinating and daunting. These conditions, often misunderstood or misdiagnosed, challenge patients and caregivers in profound ways. Brain Awareness Week is a chance to educate the public, advocate for early diagnosis, and push for research that could one day lead to better treatments or even a cure. It’s also a moment to honor the resilience of our community and the hope that drives us forward.

How CCF is Getting Involved

This year, we’re encouraging everyone to join us in raising awareness:

  • Learn and Share: Dive into resources about brain health and atypical Parkinsonism on our website at pspawareness.com. Share what you learn with friends and family to spark conversations about these conditions.
  • Support Our Mission: Your donations help us provide respite care, support groups, and advocacy for those affected. Every contribution ensures we can continue offering compassionate resources to our community.
  • Connect with Us: Follow us on social media and use hashtags like #BrainAwarenessWeek and #PSPAwareness to join the global dialogue. Let’s amplify the voices of those impacted by atypical Parkinsonism.

Brain Awareness Week isn’t just about science—it’s about people. It’s about the caregivers who show unwavering strength, the patients who inspire us daily, and the researchers working tirelessly for breakthroughs. Together, we can foster a world that better understands and supports brain health.

Join CCF from March 10-16 as we celebrate the brain’s brilliance and recommit to our mission. Let’s make this Brain Awareness Week a turning point for awareness, hope, and connection. Because at CCF, we believe that knowledge is power—and together, we can change lives.

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

  • WAITING By Bhavna

    WAITING By Bhavna

    For four years, she had lived with the unraveling of a rare brain disease. Progressive Supranuclear Palsy. Each step making her more dependent. Each fall more brutal. And each word...

    2 comments

    WAITING By Bhavna

    For four years, she had lived with the unraveling of a rare brain disease. Progressive Supranuclear Palsy. Each step making her more dependent. Each fall more brutal. And each word...

    2 comments
1 of 4